Key facts
- DeepLook Medical’s last known valuation is $17.2M (Apr 2025).
- It has raised $15.2M; the latest was Later Stage VC ($12.0M) in Dec 2025.
- Notable investors include Plug and Play Tech Center, Endless Frontier Labs, Connecticut Innovations, AZ Venture Capital, Tidal River Women's Investor Group — 19 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 19 names
- ·Watchlist + deal alerts for DeepLook Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for DeepLook Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About DeepLook Medical
Developer of a medical imaging platform designed to improve the detection of early breast cancer in mammograms. The company's platform identifies difficult-to-see data hidden in radiological images, particularly in dense breast tissue, and reveals features that are typically beyond the range of human vision, enabling physicians to decrease the number of unnecessary surgical procedures by reducing the number of false positives from mammography images.
- Sector
- Healthcare
- HQ
- New Haven, CT, United States
- Founded
- 2017
- Employees
- 9
- Website
- deeplookmedical.com/
- Ownership
- Privately Held (backing)
DeepLook Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in DeepLook Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on DeepLook Medical in its N-PORT filings yet. We sweep new filings monthly.